The calcium antagonist isradipine in the therapy of hypertension: A double-blind crossover comparison with nifedipine

D Welzel, KJ Burger - Drugs, 1990 - Springer
The calcium antagonists of the dihydropyridine group, isradipine and nifedipine, were
compared in 64 patients with mild to moderate hypertension (diastolic blood pressure 95 to …

Diversity and intensity of adverse events in the treatment of hypertension with barnidipine

JANW VAN DER VELDEN, HANJ BEUDEKER… - Blood …, 1998 - Taylor & Francis
Calcium antagonists (CaAs) are divided into three structural classes, typically represented
by verapamil, diltiazem and nifedipine. As a group, the principal (type I) adverse effects of …

Active dose findings for lercanidipine in a double-blind, placebo-controlled design in patients with mild to moderate hypertension

A Circo - Journal of Cardiovascular Pharmacology, 1997 - journals.lww.com
The purpose of the present study was to evaluate the efficacy and tolerability of lercanidipine
vs. placebo in patients with mild to moderate essential hypertension. A randomized, double …

Place of calcium antagonists in antihypertensive therapy: introduction and round-table discussion

FR Bühler, A Distler, JH Laragh… - Journal of …, 1984 - journals.lww.com
This symposium on calcium antagonists for antihypertensive baseline therapy was
overshadowed by the sudden death of Franz Gross in his Basel home on March 26, 1984 …

Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension

W Kirch, KJ Burger, G Weidinger… - Journal of cardiovascular …, 1990 - journals.lww.com
The antihypertensive efficacy and tolerability of the new calcium antagonist isradipine was
assessed in 86 hypertensive patients who had pretreatment diastolic blood pressures …

Systolic Hypertension in the Elderly: Long-Term Lacidipine Treatment: Objective, Protocol, and Organization

E Malacco, AE Gnemmi, A Romagnoli… - Journal of …, 1994 - journals.lww.com
Isolated systolic hypertension (ISH) is a definite risk factor for cardiovascular complications
(ie, cardiac failure, coronary artery disease, and stroke) independent of diastolic elevation …

Newer calcium channel antagonists and the treatment of hypertension

DF Cummins - Expert Opinion on Investigational Drugs, 1999 - Taylor & Francis
Calcium channel antagonists have become popular medications for the management of
hypertension. These agents belong to the diphenylalkylamine, benzothiazepine …

Long-term (12-month) treatment with lercanidipine in patients with mild to moderate hypertension

M Cafiero, M Giasi - Journal of Cardiovascular Pharmacology, 1997 - journals.lww.com
The long-term tolerability and antihypertensive effect of lercanidipine, a new calcium-entry
blocker, was evaluated in this open, multicenter study. A total of 355 mild to moderately …

Clinical pharmacokinetics of calcium channel antagonists

RG McAllister Jr - Journal of Cardiovascular Pharmacology, 1982 - journals.lww.com
Pharmacokinetic data are important in the development of rational regimens for drug
administration, particularly for agents with the potential for serious toxicity …

Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study

V Barrios, C Escobar, M De La Figuera… - Cardiovascular Drug …, 2008 - Wiley Online Library
The TOLERANCE study was aimed to compare the tolerability of high doses of lercanidipine
(20 mg) with that of other frequently used dihydropyridines (amlodipine 10 mg/nifedipine …